Post-treatment surveillance of patients with lymphoma treated with curative intent

Seminars in Oncology

Volumn 30, Issue 3, 2003, Pages 375-381

  Wooldridge, James E ^a   Link, Brian K ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANAMNESIS; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; EARLY DIAGNOSIS; HEALTH CARE COST; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LYMPHOMA; METASTASIS; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION HAZARD; RADIODIAGNOSIS; RECURRENT CANCER; REVIEW; STEM CELL TRANSPLANTATION; SYMPTOM; THORAX RADIOGRAPHY;

EID: 0038129924     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00096-4     Document Type: Review

References (44)

1. Jemal A, Murray T, Samuels A, et al: Cancer statistics, 2003. CA Cancer J Clin 53:5-26, 2003
2. Velasquez WS, McLaughlin P, Tucker S, et al: ES-HAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study. J Clin Oncol 12:1169-1176, 1994
3. Yuen AR, Rosenberg SA, Hoppe RT, et al: Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood 89:814-822, 1997
4. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333: 1540-1545, 1995
5. Armitage JO: The development of bone marrow transplantation as a treatment for patients with lymphoma - Twentieth Richard and Hinda Rosenthal Foundation Award Lecture. Clin Cancer Res 3:829-836, 1997
6. Loprinzi CL, Hayes D, Smith T: Doc, Shouldn't we be getting some tests? J Clin Oncol 18:2345-2348, 2000
7. Weiss NS, Cook LS: Evaluating the efficacy of screening for recurrence of cancer. J Natl Cancer Inst 90:1870-1872, 1998
8. Gallagher CJ, Gregory WM, Jones AE, et al: Follicular lymphoma: Prognostic factors for response and survival. J Clin Oncol 4:1470-1480, 1986
9. Peterson BA, Petroni GR, Frizzera G, et al: Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: A study of the Cancer and Leukemia Group B. J Clin Oncol 21:5-15, 2003
10. Miller TP, LeBlanc M, Grogan TM, et al: Follicular lymphomas: Do histologic subtypes predict outcome? Hematol Oncol Clin North Am 11:893-900, 1997
11. Neubauer A, Thiede C, Morgner A, et al: Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89:1350-1355, 1997
12. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
13. Cheson BD, Horning SJ, Coiffier B, et al: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCl Sponsored International Working Group. J Clin Oncol 17:1244, 1999
14. Coiffier B, Gisselbrecht C, Herbrecht R, et al: LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7:1018-1026, 1989
15. Surbone A, Longo DL, DeVita VT Jr, et al: Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: Significance and management. J Clin Oncol 6:1832-1837, 1988
16. Radford JA, Cowan RA, Flanagan M, et al: The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 6:940-946, 1988
17. Young RC, Canellos GP, Chabner BA, et al: Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy. Cancer 42:1001-1007, 1978
18. Yarnold JR, Jelliffe AM, Hudson GV: Patterns of relapse following radiotherapy for Hodgkin's disease. Clin Radiol 33: 137-140, 1982
19. Russell KJ, Donaldson SS, Cox RS, et al: Childhood Hodgkin's disease: Patterns of relapse. J Clin Oncol 2:80-87, 1984
20. Connors JM, Noordijk EM, Horning SJ: Hodgkin's lymphoma: Basing the treatment on the evidence. Hematology (Am Soc Hematol Educ Program) 178-193, 2001
21. Radford JA, Eardley A, Woodman C, et al: Follow up policy after treatment for Hodgkin's disease: Too many clinic visits and routine tests? A review of hospital records. BMJ 314:343-346, 1997
22. Torrey MJ, Poen JC, Hoppe RT: Detection of relapse in early-stage Hodgkin's disease: Role of routine follow-up studies. J Clin Oncol 15:1123-1130, 1997
23. Gordon LI, Harrington D, Andersen J, et al: Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 327: 1342-1349, 1992
24. Fisher RI, Gaynor ER, Dahlberg S, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002-1006, 1993
25. Shipp MA, Klatt MM, Yeap B, et al: Patterns of relapse in large-cell lymphoma patients with bulk disease: Implications for the use of adjuvant radiation therapy. J Clin Oncol 7:613-618, 1989
26. Weeks JC, Yeap BY, Canellos GP, et al: Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol 9:1196-1203, 1991
27. Armitage JO, Weisenburger DD: New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Lymphonia Classification Project. J Clin Oncol 16:2780-2795, 1998
28. Elis A, Blickstein D, Klein O, et al: Detection of relapse in non-Hodgkin's lymphoma: Role of routine follow-up studies. Am J Hematol 69:41-44, 2002
29. Boger-Megiddo I, Apter S, Spencer JA, et al: Is chest CT sufficient for follow-up of primary mediastinal B-cell lymphoma in remission? AJR Am J Roentgenol 178:165-167, 2002
30. Kostakoglu L, Goldsmith SJ: Fluorine-18 fluorodeoxy-glucose positron emission tomography in the staging and follow-up of lymphoma: Is it time to shift gears? Eur J Nucl Med 27:1564-1578, 2000
31. Naumann R, Vaic A, Beuthien-Baumann B, et al: Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Br J Haematol 115:793-800, 2001
32. Weyburn TD, Wiseman GA, Link BK, et al: FDG-PET predicts: the one year progression-free survival (1-y PFS) of patients with diffuse large B-cell lymphoma following anthracycline-based chemotherapy. Blood 100:768a, 2002 (suppl 1, abstr)
33. Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
34. Sklar C, Whitton J, Mertens A, et al: Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227-3232, 2000
35. Ding SH, Pledge SD, Harrison BJ, et al: The incidence of thyroid abnormalities in adults irradiated for lymphoma. Int J Oncol. 20:1065-1069, 2002
36. Edelman MJ, Meyers, FJ, Siegel D: The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med 12:318-331, 1997
37. Gustavsson A, Eskilsson J, Landberg T, et al: Late cardiac effects after mantle radiotherapy in patients with Hodgkin's Disease. Ann Oncol. 1:355-363, 1990
38. Hubbard SM, Longo DL: Treatment-related morbidity in patients with lymphoma. Curr Opin Oncol 3:852-862, 1991
39. Glanzmann C, Kaufmann P, Jenni R, et al: Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 46:51-62, 1998
40. Velasquez WS, Cabanillas F, Salvador P, et al: Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 71:117-122, 1988
41. Armitage JO: Bone marrow transplantation in the treatment of patients with lymphoma. Blood 73:1749-1758, 1989
42. Sureda A, Arranz R, Iriondo A, et al: Autologous; stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol 19:1395-1404, 2001
43. Caballero MD, Perez-Simon JA, Iriondo A, et al: High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 14:140-151, 2003
44. Fields PA, Goldstone AH: Non-Hodgkin's lymphomas: Clinical governance issues. Best Pract Res Clin Haematol 15: 577-596, 2002